XRCC4 and ovarian serous carcinoma: Previous studies have shown that overexpression of the XRCC4 gene was dramatically linked to worse PFS and OS for patients with serous ovarian carcinoma, suggesting the prognostic significance of XRCC4 in serous and endometrioid ovarian carcinomas patients [69].